Clinical features, sex differences and outcomes of myocardial infarction with nonobstructive coronary arteries: a registry analysis.


Journal

Coronary artery disease
ISSN: 1473-5830
Titre abrégé: Coron Artery Dis
Pays: England
ID NLM: 9011445

Informations de publication

Date de publication:
Jan 2021
Historique:
pubmed: 8 5 2020
medline: 15 12 2021
entrez: 8 5 2020
Statut: ppublish

Résumé

Clinical characteristics and outcomes of patients diagnosed with myocardial infarction (MI) with nonobstructive coronary arteries (MINOCA) remain largely unknown. Furthermore, we do not yet understand if women with MINOCA have worse outcomes similar to what has historically been observed with MI. The aims of the current study were to evaluate the (1) incidence of MINOCA in patients presenting with MI, (2) compare in-hospital outcomes of MINOCA and obstructive atherosclerotic coronary artery disease MI (OACD-MI), and (3) comparison of in-hospital clinical outcomes of patients with MINOCA stratified by sex. In this observational study, we combined data from two large university hospitals from Canada and Australia. Clinical characteristics and in-hospital outcomes of MINOCA and OACD-MI were analyzed by matching these patients in a 1:1 ratio after selecting patients with OACD-MI by systematic random sampling. Clinical characteristics associated with MINOCA were identified through multivariate logistic regression. Primary outcome of interest was net adverse cardiovascular events (NACE) defined as death, heart failure, stroke, and major bleeding. The incidence rate of MINOCA was 9.5%. Women, absence of traditional cardiac risk factors, and absence of ST-deviations on ECG were associated with diagnosis of MINOCA on angiography. NACE (P = 0.0001), death (P = 0.019), stroke (P = 0.002), and heart failure (P = 0.001) were significantly lower in patients with MINOCA. Subgroup analysis of women and men diagnosed with MINOCA revealed similar in-hospital outcomes. The incidence of MINOCA was 9.5%. Compared to OACD-MI, patients with MINOCA have less cardiac risk factors. In-hospital outcomes of patients diagnosed with MINOCA were better than OACD-MI.

Identifiants

pubmed: 32379074
doi: 10.1097/MCA.0000000000000903
pii: 00019501-202101000-00003
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

10-16

Références

Bonaca MP, Wiviott SD, Braunwald E, Murphy SA, Ruff CT, Antman EM, Morrow DA. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38). Circulation. 2012; 125:577–583
Higuma T, Soeda T, Abe N, Yamada M, Yokoyama H, Shibutani S, et al. A combined optical coherence tomography and intravascular ultrasound study on plaque rupture, plaque erosion, and calcified nodule in patients with ST-segment elevation myocardial infarction: incidence, morphologic characteristics, and outcomes after percutaneous coronary intervention. JACC Cardiovasc Interv. 2015; 8:1166–1176
DeWood MA, Stifter WF, Simpson CS, Spores J, Eugster GS, Judge TP, Hinnen ML. Coronary arteriographic findings soon after non-Q-wave myocardial infarction. N Engl J Med. 1986; 315:417–423
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al.; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction; Authors/Task Force Members Chairpersons; Biomarker Subcommittee; ECG Subcommittee; Imaging Subcommittee; Classification Subcommittee; Intervention Subcommittee; Trials & Registries Subcommittee; Trials & Registries Subcommittee; Trials & Registries Subcommittee; Trials & Registries Subcommittee; ESC Committee for Practice Guidelines (CPG); Document Reviewers. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012; 60:1581–1598
Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio AL, et al.; WG on Cardiovascular Pharmacotherapy. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J. 2017; 38:143–153
Le May MR, So DY, Dionne R, Glover CA, Froeschl MP, Wells GA, et al. A citywide protocol for primary PCI in ST-segment elevation myocardial infarction. N Engl J Med. 2008; 358:231–240
Tamis-Holland JE, Jneid H, Reynolds HR, Agewall S, Brilakis ES, Brown TM, et al. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association. Circulation. 2019; 139:e891–e908
Ezekowitz JA, O’Meara E, McDonald MA, Abrams H, Chan M, Ducharme A, et al. 2017 comprehensive update of the Canadian cardiovascular society guidelines for the management of heart failure. Can J Cardiol. 2017; 33:1342–1433
Pasupathy S, Air T, Dreyer RP, Tavella R, Beltrame JF. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation. 2015; 131:861–870
Patel MR, Chen AY, Peterson ED, Newby LK, Pollack CV Jr, Brindis RG, et al. Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the can rapid risk stratification of unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative. Am Heart J. 2006; 152:641–647
Larsen AI, Nilsen DW, Yu J, Mehran R, Nikolsky E, Lansky AJ, et al. Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial). Am J Cardiol. 2013; 111:643–648
Barr PR, Harrison W, Smyth D, Flynn C, Lee M, Kerr AJ. Myocardial infarction without obstructive coronary artery disease is not a benign condition (ANZACS-QI 10). Heart Lung Circ. 2018; 27:165–174
Lacruz ME, Kluttig A, Hartwig S, Löer M, Tiller D, Greiser KH, et al. Prevalence and incidence of hypertension in the general adult population: results of the CARLA-cohort study. Medicine (Baltimore). 2015; 94:e952
Catalán-Ramos A, Verdú JM, Grau M, Iglesias-Rodal M, del Val García JL, Consola A, Comin E; @GPC-ICS Group. Population prevalence and control of cardiovascular risk factors: what electronic medical records tell us. Aten Primaria. 2014; 46:15–24
Eggers KM, Hjort M, Baron T, Jernberg T, Nordenskjöld AM, Tornvall P, Lindahl B. Morbidity and cause-specific mortality in first-time myocardial infarction with nonobstructive coronary arteries. J Intern Med. 2019; 285:419–428
Wijesurendra RS, Casadei B. Atrial fibrillation: effects beyond the atrium? Cardiovasc Res. 2015; 105:238–247
Wijesurendra RS, Liu A, Notaristefano F, Ntusi NAB, Karamitsos TD, Bashir Y, et al. Myocardial perfusion is impaired and relates to cardiac dysfunction in patients with atrial fibrillation both before and after successful catheter ablation. J Am Heart Assoc. 2018; 7:e009218
Kochiadakis GE, Skalidis EI, Kalebubas MD, Igoumenidis NE, Chrysostomakis SI, Kanoupakis EM, et al. Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans. Eur Heart J. 2002; 23:734–741
Range FT, Schäfers M, Acil T, Schäfers KP, Kies P, Paul M, et al. Impaired myocardial perfusion and perfusion reserve associated with increased coronary resistance in persistent idiopathic atrial fibrillation. Eur Heart J. 2007; 28:2223–2230
Safdar B, Spatz ES, Dreyer RP, Beltrame JF, Lichtman JH, Spertus JA, et al. Presentation, clinical profile, and prognosis of young patients with myocardial infarction with nonobstructive coronary arteries (MINOCA): results from the VIRGO study. J Am Heart Assoc. 2018; 7:e009174
Singh K, Carson K, Shah R, Sawhney G, Singh B, Parsaik A, et al. Meta-analysis of clinical correlates of acute mortality in Takotsubo cardiomyopathy. Am J Cardiol. 2014; 113:1420–1428

Auteurs

Richard G Jung (RG)

Department of Cardiology.
CAPITAL Research Group.
Department of Cellular and Molecular Medicine, Faculty of Medicine.

Simon Parlow (S)

Department of Cardiology.
Department of Medicine, University of Ottawa, Ontario, Canada.

Trevor Simard (T)

Department of Cardiology.
CAPITAL Research Group.
Department of Cellular and Molecular Medicine, Faculty of Medicine.

Christopher Chen (C)

Department of Medicine, Bond University, Varsity Lakes, QLD Australia.

Harshpreet Ghataura (H)

Department of Medicine, Bond University, Varsity Lakes, QLD Australia.

Aditya Kishore (A)

Department of Medicine, Bond University, Varsity Lakes, QLD Australia.

Aravinda Perera (A)

Department of Medicine, Bond University, Varsity Lakes, QLD Australia.

Rob Moreland (R)

CAPITAL Research Group.
Department of Radiology, University of Ottawa, Ottawa, Ontario, Canada.
Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Ian Hughes (I)

Department of Cardiology Gold Coast University Hospital, Southport QLD.
School of Medicine, The University of Queensland, St. Lucia, QLD, Australia.

Rosanna Tavella (R)

Department of Medicine, University of Adelaide, Adelaide South Australia.

Benjamin Hibbert (B)

Department of Cardiology.
CAPITAL Research Group.
Department of Cellular and Molecular Medicine, Faculty of Medicine.

John Beltrame (J)

Department of Medicine, University of Adelaide, Adelaide South Australia.

Kuljit Singh (K)

Department of Medicine, Bond University, Varsity Lakes, QLD Australia.
Department of Medicine, University of Adelaide, Adelaide South Australia.
Department of Cardiology Gold Coast University Hospital, Southport QLD.
School of Medicine, The University of Queensland, St. Lucia, QLD, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH